Likely active: portfolio news Jun 2025 Verified 7 Nov 2026
Segulah Medical Acceleration (SMA)
Stockholm-based medtech investor that backs growth and early commercialisation stage medical device, diagnostics, life science tools and healthtech companies in Europe with a Nordic focus.
- Type
- VC firm
- Location
- Stockholm, Sweden
- Stages
- Series A, Growth
- Sectors
- Healthtech and life sciences, Medtech, Diagnostics, Life Science Tools
- Fund size / AUM
- SEK 1.3bn (about EUR 120M) assets under management (own site)
- Website
- segulahmedical.com
Contacts on file
For Segulah Medical Acceleration (SMA), the paid file holds: 3 named decision-makers with roles; firm contact email (domain checked); check size; how to pitch (the route the firm publishes); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
SAGA DiagnosticsSenzimeCollective Minds RadiologyNavinci DiagnosticsQuanta Dialysis Technologies
Sources
- segulahmedical.com/
- segulahmedical.com/team/
- segulahmedical.com/portfolio/
- segulahmedical.com/contact/
- segulahmedical.com/cmrad-investment/
- www.svca.se/ordinarie-medlemmar/
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 17 lists
Startup investors in Stockholm (20)Venture capital firms in Sweden (27)Startup investors in Sweden (35)Medtech investors in Europe (45)Growth-stage medtech investors (107)Series A medtech investors (125)Growth-stage investors in Europe (276)Healthtech investors in Europe (291)Growth-stage healthtech investors (316)Series A investors in Europe (329)Series A healthtech investors (401)Venture capital firms in Europe (412)Medtech investors (457)Growth-stage investors (705)Startup investors in Europe (725)Series A investors (864)Healthtech investors (1,207)